What’s Up with the Dalai Lama?

Leaves Mayo Clinic after 'routine checkup'

Tibet’s exiled Buddhist spiritual leader, the Dalai Lama, has left the Mayo Clinic in Rochester, Minnesota, after what his office called a routine annual check-up, hospital officials have said.

The 80-year-old Nobel Peace laureate canceled planned visits in the United States in October at the advice of doctors who urged him to rest for several weeks, his office said Friday in a statement.

His office gave no indication that he was ill nor any details about his state of health.

Related: Governing the Faithful

Mayo spokeswoman Ginger Plumbo said he had been released, but declined to provide any information as to when he left or further details on his stay.

The Dalai Lama’s office could not immediately be reached for comment.

Do you support individual military members being able to opt out of getting the COVID vaccine?

By completing the poll, you agree to receive emails from LifeZette, occasional offers from our partners and that you've read and agree to our privacy policy and legal statement.

His time in the country coincided with the visit of Pope Francis, who met with President Barack Obama and left to return to Rome on Sunday night after a 10-day trip to the United States and Cuba.

[lz_ndn video=29749783]

The local Post-Bulletin newspaper said dozens of Tibetans clad in traditional clothes greeted the Dalai Lama on Wednesday morning at the Mayo Civic Center.

“It means the world to us,” Dorjee Damdul told the newspaper. “We follow his guidance … he touched our faces. It was a blessing.”

China has ruled Tibet with an iron fist since communist troops took over the region in 1950. Beijing regards the Dalai Lama, who fled into exile in India in 1959, as a dangerous separatist who wants an independent Tibet.

The Dalai Lama has repeatedly refuted those claims and has advocated for seeking greater autonomy for Tibet within China through dialogue with Beijing.

This article originally appeared in Religion News Service and in Reuters.

Join the Discussion

Comments are currently closed.